GDMC manufactures and designs genetic medicines using advanced gene editing techniques to create targeted therapies for genetic disorders. The company addresses the need for effective treatments by providing precision medicine solutions that improve patient outcomes and reduce healthcare costs.
Funding
$15.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many genetic disorders lack effective treatments, creating a need for targeted therapies that can address the underlying genetic causes of these conditions. The development of such therapies is often hampered by the complexity of gene editing and the challenges of delivering genetic medicines to the right cells and tissues.
Solution
GDMC designs and manufactures genetic medicines using advanced gene editing techniques to create targeted therapies for genetic disorders. The company focuses on providing precision medicine solutions that aim to improve patient outcomes. By leveraging advanced gene editing, GDMC develops therapies designed to address the root causes of genetic diseases with greater precision and efficacy.
Target Audience
GDMC's primary customers are patients with genetic disorders and healthcare providers seeking effective, targeted treatment options.
Features
- Advanced gene editing techniques for precise targeting of genetic mutations
- Development of targeted therapies for a range of genetic disorders
- Precision medicine solutions tailored to individual patient needs